• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬:肝脏脂肪毒性的细胞保护机制

Autophagy: A Cellular Guardian against Hepatic Lipotoxicity.

机构信息

Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.

出版信息

Genes (Basel). 2023 Feb 23;14(3):553. doi: 10.3390/genes14030553.

DOI:10.3390/genes14030553
PMID:36874473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7614268/
Abstract

Lipotoxicity is a phenomenon of lipid-induced cellular injury in nonadipose tissue. Excess of free saturated fatty acids (SFAs) contributes to hepatic injury in nonalcoholic fatty liver disease (NAFLD), which has been growing at an unprecedented rate in recent years. SFAs and their derivatives such as ceramides and membrane phospholipids have been shown to induce intrahepatic oxidative damage and ER stress. Autophagy represents a cellular housekeeping mechanism to counter the perturbation in organelle function and activation of stress signals within the cell. Several aspects of autophagy, including lipid droplet assembly, lipophagy, mitophagy, redox signaling and ER-phagy, play a critical role in mounting a strong defense against lipotoxic lipid species within the hepatic cells. This review provides a succinct overview of our current understanding of autophagy-lipotoxicity interaction and its pharmacological and nonpharmacological modulation in treating NAFLD.

摘要

脂毒性是指非脂肪组织中脂质诱导的细胞损伤现象。过量的游离饱和脂肪酸(SFAs)导致非酒精性脂肪性肝病(NAFLD)中的肝损伤,近年来该病的发病率呈前所未有的速度增长。SFAs 及其衍生物,如神经酰胺和膜磷脂,已被证明可诱导肝内氧化损伤和内质网应激。自噬代表了一种细胞自我维持机制,可对抗细胞器功能障碍和细胞内应激信号的激活。自噬的几个方面,包括脂滴组装、脂噬、线粒体自噬、氧化还原信号和内质网自噬,在抵御肝细胞内的脂毒性脂质方面发挥着关键作用。本综述简要概述了我们目前对自噬-脂毒性相互作用及其在治疗 NAFLD 中的药理学和非药理学调节的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7b/10048193/5cffcf03e199/genes-14-00553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7b/10048193/5cffcf03e199/genes-14-00553-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7b/10048193/5cffcf03e199/genes-14-00553-g001.jpg

相似文献

1
Autophagy: A Cellular Guardian against Hepatic Lipotoxicity.自噬:肝脏脂肪毒性的细胞保护机制
Genes (Basel). 2023 Feb 23;14(3):553. doi: 10.3390/genes14030553.
2
Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.油酸通过缓解自噬功能障碍改善肝脏脂肪毒性损伤。
Exp Cell Res. 2023 Aug 15;429(2):113655. doi: 10.1016/j.yexcr.2023.113655. Epub 2023 May 28.
3
Natural Product Skatole Ameliorates Lipotoxicity-Induced Multiple Hepatic Damage under Hyperlipidemic Conditions in Hepatocytes.天然产物粪臭素可改善高脂条件下肝细胞脂毒性诱导的多种肝损伤。
Nutrients. 2023 Mar 20;15(6):1490. doi: 10.3390/nu15061490.
4
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.非酒精性脂肪性肝病与肝纤维化分期。
Adv Exp Med Biol. 2024;1460:539-574. doi: 10.1007/978-3-031-63657-8_18.
5
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.非酒精性脂肪性肝炎的发病机制:营养过剩的代谢并发症如何导致脂毒性和促炎脂肪性肝病。
Adv Exp Med Biol. 2018;1061:19-44. doi: 10.1007/978-981-10-8684-7_3.
6
Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病
Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.
7
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的脂质组学生物标志物和脂毒性机制。
Free Radic Biol Med. 2019 Nov 20;144:293-309. doi: 10.1016/j.freeradbiomed.2019.05.029. Epub 2019 May 29.
8
Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells.ULK1 的缺失会增加 RPS6KB1-NCOR1 对 NR1H/LXR 介导的 Scd1 转录的抑制作用,并增强肝细胞的脂毒性。
Autophagy. 2017 Jan 2;13(1):169-186. doi: 10.1080/15548627.2016.1235123. Epub 2016 Nov 15.
9
Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic Injury Modulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress Pathways.异甜菊醇通过调节蛋白激酶 C-β/p66Shc/活性氧和内质网应激途径保护游离脂肪酸和高脂饮食诱导的肝损伤。
Antioxid Redox Signal. 2019 Jun 10;30(17):1949-1968. doi: 10.1089/ars.2018.7521. Epub 2019 Jan 28.
10
Inositol-requiring enzyme 1α links palmitate-induced mTOR activation and lipotoxicity in hepatocytes.肌醇需求酶 1α 将软脂酸诱导的 mTOR 激活与肝细胞的脂毒性联系起来。
Am J Physiol Cell Physiol. 2020 Dec 1;319(6):C1130-C1140. doi: 10.1152/ajpcell.00165.2020. Epub 2020 Oct 14.

引用本文的文献

1
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions.揭开胰岛素抵抗之谜:从主要机制见解、后果到治疗干预
Int J Mol Sci. 2025 Mar 19;26(6):2770. doi: 10.3390/ijms26062770.
2
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.代谢功能障碍相关脂肪性肝病:一种具有异质性代谢风险因素、机制和合并症且需要整体治疗的疾病。
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):314-328. doi: 10.1038/s41575-025-01045-z. Epub 2025 Feb 17.
3

本文引用的文献

1
Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges.甲状腺激素受体-β激动剂在非酒精性脂肪性肝病治疗中的应用:可能性与挑战。
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1602-1613. doi: 10.1210/clinem/dgad072.
2
Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet.适度的跑步机运动通过调节脂滴的生物发生和自噬来缓解非酒精性脂肪性肝病。
Nutrients. 2022 Nov 20;14(22):4910. doi: 10.3390/nu14224910.
3
Mitochondrial alterations in fatty liver diseases.脂肪性肝病中的线粒体改变
Higher levels of plasmatic saturated fatty acid were significantly associated with liver fibrosis in HIV mono-infection: A case-control study.
在HIV单一感染中,较高水平的血浆饱和脂肪酸与肝纤维化显著相关:一项病例对照研究。
Metabol Open. 2024 Nov 29;24:100334. doi: 10.1016/j.metop.2024.100334. eCollection 2024 Dec.
4
Lipids associated with autophagy: mechanisms and therapeutic targets.与自噬相关的脂质:机制与治疗靶点。
Cell Death Discov. 2024 Oct 30;10(1):460. doi: 10.1038/s41420-024-02224-8.
5
Thyroid Hormone-Mediated Selective Autophagy and Its Implications in Countering Metabolic Dysfunction-Associated Steatotic Liver Disease.甲状腺激素介导的选择性自噬及其在对抗代谢功能障碍相关脂肪性肝病中的作用。
Endocrinol Metab (Seoul). 2024 Oct;39(5):686-692. doi: 10.3803/EnM.2024.2068. Epub 2024 Oct 14.
6
Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.自噬与肝脏脂质代谢:非酒精性脂肪性肝病的机制洞察与治疗潜力
NPJ Metab Health Dis. 2024;2(1):19. doi: 10.1038/s44324-024-00022-5. Epub 2024 Aug 2.
7
Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease.自噬在肝脏中的细胞类型特异性作用及其在非酒精性脂肪性肝病中的意义。
World J Hepatol. 2023 Dec 27;15(12):1272-1283. doi: 10.4254/wjh.v15.i12.1272.
8
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.代谢功能障碍相关性脂肪性肝病及其病理生理学、与动脉粥样硬化和心血管疾病的关联,以及治疗方法。
Int J Mol Sci. 2023 Oct 23;24(20):15473. doi: 10.3390/ijms242015473.
9
Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH.靶向细胞外 RNA 可减轻 NASH 的肝脂肪毒性和肝损伤。
Cells. 2023 Jul 13;12(14):1845. doi: 10.3390/cells12141845.
J Hepatol. 2023 Feb;78(2):415-429. doi: 10.1016/j.jhep.2022.09.020. Epub 2022 Oct 7.
4
Exercise during weight loss improves hepatic mitophagy.减肥期间进行运动可改善肝脏线粒体自噬。
Sports Med Health Sci. 2022 Apr 12;4(3):183-189. doi: 10.1016/j.smhs.2022.04.003. eCollection 2022 Sep.
5
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target.代谢相关性脂肪性肝病中自噬失调:一个新的治疗靶点。
Int J Mol Sci. 2022 Sep 2;23(17):10055. doi: 10.3390/ijms231710055.
6
BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy.BL-918,一种 ULK1 的小分子激活剂,可诱导保护性自噬,用于肌萎缩侧索硬化症的治疗。
Acta Pharmacol Sin. 2023 Mar;44(3):524-537. doi: 10.1038/s41401-022-00972-w. Epub 2022 Aug 30.
7
Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology.线粒体、线粒体自噬和去泛素化酶作为肝脏病理学新的治疗靶点的作用。
J Cell Biochem. 2022 Oct;123(10):1634-1646. doi: 10.1002/jcb.30312. Epub 2022 Aug 4.
8
Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation.用于治疗异常脂质蓄积的自噬诱导颗粒的设计与评估
Pharmaceutics. 2022 Jun 29;14(7):1379. doi: 10.3390/pharmaceutics14071379.
9
Vitamin B and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation.维生素B和叶酸通过阻止Syntaxin 17同型半胱氨酸化来减轻非酒精性脂肪性肝炎中的炎症和纤维化。
J Hepatol. 2022 Nov;77(5):1246-1255. doi: 10.1016/j.jhep.2022.06.033. Epub 2022 Jul 9.
10
Ceramide de novo synthesis in non-alcoholic fatty liver disease: Pathogenic mechanisms and therapeutic perspectives.非酒精性脂肪性肝病中神经酰胺的从头合成:致病机制与治疗前景
Biochem Pharmacol. 2022 Aug;202:115157. doi: 10.1016/j.bcp.2022.115157. Epub 2022 Jun 28.